(The Translational Genomics Research Institute) Researchers at the Translational Genomics Research Institute today announced a new approach to treating endometrial cancer patients that not only stops the growth of tumors, but kills the cancer cells.In a potentially major breakthrough, TGen scientists and collaborators at Washington University School of Medicine in St.

Louis discovered that introducing a particular inhibitor drug can turn "off'' receptors responsible for the growth of tumors in a significant number of patients with endometrial cancer.